|
Scilin M30 (30/70)
Insulin nguoi tron, hon hop
- Strength / route
- 100UI/ml ; 3ml · Injection
- Qty
- 1,000 Ampoule
- Total
- 94,649,000
- Group
- N1
- Manufacturer
- Bioton S.A (Ba Lan)
- Province / Facility
- Hanoi · 01E53
|
590410647424 |
100UI/ml ; 3ml
Injection
|
Ampoule |
1,000
|
94,649
|
94,649,000
|
N1 |
Bioton S.A
Ba Lan
|
Hanoi
01E53
|
2026-03-27 |
|
Scilin M30 (30/70)
Insulin nguoi tron, hon hop
- Strength / route
- 100UI/ml ; 3ml · Injection
- Qty
- 1,000 Ampoule
- Total
- 94,649,000
- Group
- N1
- Manufacturer
- Bioton S.A (Ba Lan)
- Province / Facility
- Hanoi · 01E64
|
590410647424 |
100UI/ml ; 3ml
Injection
|
Ampoule |
1,000
|
94,649
|
94,649,000
|
N1 |
Bioton S.A
Ba Lan
|
Hanoi
01E64
|
2026-03-27 |
|
Scilin M30 (30/70)
Insulin nguoi tron, hon hop
- Strength / route
- 100UI/ml ; 3ml · Injection
- Qty
- 1,000 Ampoule
- Total
- 94,649,000
- Group
- N1
- Manufacturer
- Bioton S.A (Ba Lan)
- Province / Facility
- Hanoi · 01E58
|
590410647424 |
100UI/ml ; 3ml
Injection
|
Ampoule |
1,000
|
94,649
|
94,649,000
|
N1 |
Bioton S.A
Ba Lan
|
Hanoi
01E58
|
2026-03-27 |
|
Seduxen 5mg
Diazepam
- Strength / route
- 5mg · Oral
- Qty
- 10 Tablet
- Total
- 19,320
- Group
- N1
- Manufacturer
- Gedeon Richter Plc. (Hungary)
- Province / Facility
- Ho Chi Minh City · 79026
|
599112027923 |
5mg
Oral
|
Tablet |
10
|
1,932
|
19,320
|
N1 |
Gedeon Richter Plc.
Hungary
|
Ho Chi Minh City
79026
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Oral inhalation
- Qty
- 200 Canister
- Total
- 39,977,600
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hai Duong · 30013
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Oral inhalation
|
Canister |
200
|
199,888
|
39,977,600
|
N1 |
GlaxoSmithKline LLC
USA
|
Hai Duong
30013
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Inhalation
- Qty
- 100 Canister
- Total
- 19,988,800
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hanoi · 01107
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Inhalation
|
Canister |
100
|
199,888
|
19,988,800
|
N1 |
GlaxoSmithKline LLC
USA
|
Hanoi
01107
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Inhalation
- Qty
- 100 Canister
- Total
- 19,988,800
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hanoi · 01OR2
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Inhalation
|
Canister |
100
|
199,888
|
19,988,800
|
N1 |
GlaxoSmithKline LLC
USA
|
Hanoi
01OR2
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Inhalation
- Qty
- 100 Canister
- Total
- 19,988,800
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hanoi · 01E53
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Inhalation
|
Canister |
100
|
199,888
|
19,988,800
|
N1 |
GlaxoSmithKline LLC
USA
|
Hanoi
01E53
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Inhalation
- Qty
- 100 Canister
- Total
- 19,988,800
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hanoi · 01E64
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Inhalation
|
Canister |
100
|
199,888
|
19,988,800
|
N1 |
GlaxoSmithKline LLC
USA
|
Hanoi
01E64
|
2026-03-27 |
|
Seretide Accuhaler 50/250mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg · Inhalation
- Qty
- 100 Canister
- Total
- 19,988,800
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (USA)
- Province / Facility
- Hanoi · 01E58
|
001110013824 |
each dose hit contains: Salmeterol (as Salmeterol xinafoate) 50mcg; Fluticason propionat 250mcg
Inhalation
|
Canister |
100
|
199,888
|
19,988,800
|
N1 |
GlaxoSmithKline LLC
USA
|
Hanoi
01E58
|
2026-03-27 |
|
Seretide Accuhaler 50/500mcg
Salmeterol+ fluticason propionat
- Strength / route
- 50mcg/ 500mcg · Oral inhalation
- Qty
- 500 Canister
- Total
- 109,306,000
- Group
- N1
- Manufacturer
- GlaxoSmithKline LLC (United States)
- Province / Facility
- Hai Duong · 30013
|
VN-20767-17 |
50mcg/ 500mcg
Oral inhalation
|
Canister |
500
|
218,612
|
109,306,000
|
N1 |
GlaxoSmithKline LLC
United States
|
Hai Duong
30013
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- 25mcg + 250mcg; 120 dose · Inhalation
- Qty
- 300 Canister
- Total
- 83,427,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Thai Nguyen · 19013
|
840110788024 |
25mcg + 250mcg; 120 dose
Inhalation
|
Canister |
300
|
278,090
|
83,427,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Thai Nguyen
19013
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg · Inhalation
- Qty
- 100 Spray canister
- Total
- 27,809,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Hanoi · 01107
|
840110788024 |
each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg
Inhalation
|
Spray canister |
100
|
278,090
|
27,809,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Hanoi
01107
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg · Inhalation
- Qty
- 100 Spray canister
- Total
- 27,809,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Hanoi · 01OR2
|
840110788024 |
each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg
Inhalation
|
Spray canister |
100
|
278,090
|
27,809,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Hanoi
01OR2
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg · Inhalation
- Qty
- 100 Spray canister
- Total
- 27,809,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Hanoi · 01E53
|
840110788024 |
each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg
Inhalation
|
Spray canister |
100
|
278,090
|
27,809,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Hanoi
01E53
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg · Inhalation
- Qty
- 100 Spray canister
- Total
- 27,809,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Hanoi · 01E64
|
840110788024 |
each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg
Inhalation
|
Spray canister |
100
|
278,090
|
27,809,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Hanoi
01E64
|
2026-03-27 |
|
Seretide Evohaler DC 25/250 mcg
Salmeterol+ fluticason propionat
- Strength / route
- each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg · Inhalation
- Qty
- 100 Spray canister
- Total
- 27,809,000
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Hanoi · 01E58
|
840110788024 |
each dose xit contains: Salmeterol (as salmeterol xinafoate micronised) 25mcg and Fluticason propionate (dang micronised) 250mcg
Inhalation
|
Spray canister |
100
|
278,090
|
27,809,000
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Hanoi
01E58
|
2026-03-27 |
|
Seroquel XR
Quetiapin
- Strength / route
- 300mg · Oral
- Qty
- 8,000 Tablet
- Total
- 266,560,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited. (Country of manufacture: United States; Country of packaging: United Kingdom)
- Province / Facility
- Hanoi · 01055
|
VN-22284-19 |
300mg
Oral
|
Tablet |
8,000
|
33,320
|
266,560,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited.
Country of manufacture: United States; Country of packaging: United Kingdom
|
Hanoi
01055
|
2026-03-27 |
|
Seroquel XR
Quetiapin
- Strength / route
- 200mg · Oral
- Qty
- 8,000 Tablet
- Total
- 175,168,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited. (Country of manufacture: United States; Country of packaging: United Kingdom)
- Province / Facility
- Hanoi · 01055
|
VN-22283-19 |
200mg
Oral
|
Tablet |
8,000
|
21,896
|
175,168,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited.
Country of manufacture: United States; Country of packaging: United Kingdom
|
Hanoi
01055
|
2026-03-27 |
|
Seroquel XR
Quetiapin
- Strength / route
- 50mg · Oral
- Qty
- 8,000 Tablet
- Total
- 83,776,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited. (Country of manufacture: United States; Country of packaging: United Kingdom)
- Province / Facility
- Hanoi · 01055
|
VN-22285-19 |
50mg
Oral
|
Tablet |
8,000
|
10,472
|
83,776,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging site: AstraZeneca UK Limited.
Country of manufacture: United States; Country of packaging: United Kingdom
|
Hanoi
01055
|
2026-03-27 |
|
Sevorane
Sevofluran
- Strength / route
- 100% x 250ml · Inhalation
- Qty
- 100 Chai
- Total
- 357,850,000
- Group
- N1
- Manufacturer
- Abbvie S.R.L (Italy)
- Province / Facility
- Thai Nguyen · 19013
|
800114034723 |
100% x 250ml
Inhalation
|
Chai |
100
|
3,578,500
|
357,850,000
|
N1 |
Abbvie S.R.L
Italy
|
Thai Nguyen
19013
|
2026-03-27 |
|
Silymarin VCP
Sylimarin
- Strength / route
- 140 mg · Oral
- Qty
- 50,000 Tablet
- Total
- 60,000,000
- Group
- N4
- Manufacturer
- VCP Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thai Binh · 34002
|
893200192725 |
140 mg
Oral
|
Tablet |
50,000
|
1,200
|
60,000,000
|
N4 |
VCP Pharmaceutical JSC
Vietnam
|
Thai Binh
34002
|
2026-03-27 |
|
Simponi
Golimumab
- Strength / route
- 50mg/0,5ml · Injection
- Qty
- 65 Pen injector
- Total
- 779,886,835
- Group
- N1
- Manufacturer
- Manufacturing site: Baxter Pharmaceutical Solutions LLC, Packaging and batch release site: Cilag AG (Country of manufacture: United States, Country of packaging and batch release: Switzerland)
- Province / Facility
- Quang Nam · 49004
|
001410037423 |
50mg/0,5ml
Injection
|
Pen injector |
65
|
11,998,259
|
779,886,835
|
N1 |
Manufacturing site: Baxter Pharmaceutical Solutions LLC, Packaging and batch release site: Cilag AG
Country of manufacture: United States, Country of packaging and batch release: Switzerland
|
Quang Nam
49004
|
2026-03-27 |
|
Sinh địa
Sinh dia
- Strength / route
- Oral
- Qty
- 40,000 Gam
- Total
- 4,800,000
- Group
- N2
- Manufacturer
- Fitopharma Pharmaceutical Co., Ltd. (Vietnam)
- Province / Facility
- Hanoi · 01065
|
VCT-00467-23 |
Oral
|
Gam |
40,000
|
120
|
4,800,000
|
N2 |
Fitopharma Pharmaceutical Co., Ltd.
Vietnam
|
Hanoi
01065
|
2026-03-27 |
|
Solu-Medrol
Methylprednisolon (as Methylprednisolon sodium succinate)
- Strength / route
- 40mg · Injection
- Qty
- 3,500 Vial
- Total
- 146,548,500
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Bỉ)
- Province / Facility
- Hai Duong · 30013
|
VN-20330-17 |
40mg
Injection
|
Vial |
3,500
|
41,871
|
146,548,500
|
N1 |
Pfizer Manufacturing Belgium NV
Bỉ
|
Hai Duong
30013
|
2026-03-27 |
|
Solu-Medrol
Methyl prednisolon
- Strength / route
- 40mg · Injection
- Qty
- 700 Vial
- Total
- 29,309,700
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Belgium)
- Province / Facility
- Thai Nguyen · 19013
|
VN-20330-17 |
40mg
Injection
|
Vial |
700
|
41,871
|
29,309,700
|
N1 |
Pfizer Manufacturing Belgium NV
Belgium
|
Thai Nguyen
19013
|
2026-03-27 |
|
Solu-Medrol
Methyl prednisolon
- Strength / route
- 40mg · Injection
- Qty
- 23,000 Vial
- Total
- 963,033,000
- Group
- N1
- Manufacturer
- Pfizer Manufacturing Belgium NV (Bỉ)
- Province / Facility
- Hanoi · 01055
|
VN-20330-17 |
40mg
Injection
|
Vial |
23,000
|
41,871
|
963,033,000
|
N1 |
Pfizer Manufacturing Belgium NV
Bỉ
|
Hanoi
01055
|
2026-03-27 |
|
Sorbitol
Sorbitol
- Strength / route
- 5g · Oral
- Qty
- 100 Sachet
- Total
- 74,500
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Ngai · 51116
|
893100244125 |
5g
Oral
|
Sachet |
100
|
745
|
74,500
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Quang Ngai
51116
|
2026-03-27 |
|
Sorbitol
Sorbitol
- Strength / route
- 5g · Oral
- Qty
- 100 Sachet
- Total
- 74,500
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Ngai · 51069
|
893100244125 |
5g
Oral
|
Sachet |
100
|
745
|
74,500
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Quang Ngai
51069
|
2026-03-27 |
|
Sorbitol
Sorbitol
- Strength / route
- 5g · Oral
- Qty
- 100 Sachet
- Total
- 74,500
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Ngai · 51070
|
893100244125 |
5g
Oral
|
Sachet |
100
|
745
|
74,500
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Quang Ngai
51070
|
2026-03-27 |
|
Sorbitol
Sorbitol
- Strength / route
- 5g · Oral
- Qty
- 2,000 Sachet
- Total
- 1,490,000
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Ngai · 51225
|
893100244125 |
5g
Oral
|
Sachet |
2,000
|
745
|
1,490,000
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Quang Ngai
51225
|
2026-03-27 |
|
Sorbitol
Sorbitol
- Strength / route
- 5g · Oral
- Qty
- 20,000 Sachet
- Total
- 14,900,000
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Ngai · 51002
|
893100244125 |
5g
Oral
|
Sachet |
20,000
|
745
|
14,900,000
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Quang Ngai
51002
|
2026-03-27 |
|
Stacytine 200
N-acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 30,000 Tablet
- Total
- 51,180,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hanoi · 01107
|
893100107723 |
200mg
Oral
|
Tablet |
30,000
|
1,706
|
51,180,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hanoi
01107
|
2026-03-27 |
|
Stacytine 200
N-acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 30,000 Tablet
- Total
- 51,180,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hanoi · 01OR2
|
893100107723 |
200mg
Oral
|
Tablet |
30,000
|
1,706
|
51,180,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hanoi
01OR2
|
2026-03-27 |
|
Stacytine 200
N-acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 30,000 Tablet
- Total
- 51,180,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hanoi · 01E53
|
893100107723 |
200mg
Oral
|
Tablet |
30,000
|
1,706
|
51,180,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hanoi
01E53
|
2026-03-27 |
|
Stacytine 200
N-acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 30,000 Tablet
- Total
- 51,180,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hanoi · 01E64
|
893100107723 |
200mg
Oral
|
Tablet |
30,000
|
1,706
|
51,180,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hanoi
01E64
|
2026-03-27 |
|
Stacytine 200
N-acetylcystein
- Strength / route
- 200mg · Oral
- Qty
- 30,000 Tablet
- Total
- 51,180,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Hanoi · 01E58
|
893100107723 |
200mg
Oral
|
Tablet |
30,000
|
1,706
|
51,180,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Hanoi
01E58
|
2026-03-27 |
|
Stadfovir 25
Tenofovir alafenamide
- Strength / route
- 25 mg · Oral
- Qty
- 5,000 Tablet
- Total
- 47,500,000
- Group
- N2
- Manufacturer
- Stellapharm J.V. Co., Ltd. – Branch 1 (Vietnam)
- Province / Facility
- Thai Binh · 34002
|
893110005823 |
25 mg
Oral
|
Tablet |
5,000
|
9,500
|
47,500,000
|
N2 |
Stellapharm J.V. Co., Ltd. – Branch 1
Vietnam
|
Thai Binh
34002
|
2026-03-27 |
|
Sucralfat DWP 1000mg
Sucralfat
- Strength / route
- 1g · Oral
- Qty
- 33,500 Tablet
- Total
- 33,064,500
- Group
- N5
- Manufacturer
- Wealphar Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01107
|
893100031524 |
1g
Oral
|
Tablet |
33,500
|
987
|
33,064,500
|
N5 |
Wealphar Pharmaceutical JSC
Vietnam
|
Hanoi
01107
|
2026-03-27 |
|
Sucralfat DWP 1000mg
Sucralfat
- Strength / route
- 1g · Oral
- Qty
- 33,500 Tablet
- Total
- 33,064,500
- Group
- N5
- Manufacturer
- Wealphar Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01OR2
|
893100031524 |
1g
Oral
|
Tablet |
33,500
|
987
|
33,064,500
|
N5 |
Wealphar Pharmaceutical JSC
Vietnam
|
Hanoi
01OR2
|
2026-03-27 |
|
Sucralfat DWP 1000mg
Sucralfat
- Strength / route
- 1g · Oral
- Qty
- 33,500 Tablet
- Total
- 33,064,500
- Group
- N5
- Manufacturer
- Wealphar Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E53
|
893100031524 |
1g
Oral
|
Tablet |
33,500
|
987
|
33,064,500
|
N5 |
Wealphar Pharmaceutical JSC
Vietnam
|
Hanoi
01E53
|
2026-03-27 |
|
Sucralfat DWP 1000mg
Sucralfat
- Strength / route
- 1g · Oral
- Qty
- 33,500 Tablet
- Total
- 33,064,500
- Group
- N5
- Manufacturer
- Wealphar Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E64
|
893100031524 |
1g
Oral
|
Tablet |
33,500
|
987
|
33,064,500
|
N5 |
Wealphar Pharmaceutical JSC
Vietnam
|
Hanoi
01E64
|
2026-03-27 |
|
Sucralfat DWP 1000mg
Sucralfat
- Strength / route
- 1g · Oral
- Qty
- 33,500 Tablet
- Total
- 33,064,500
- Group
- N5
- Manufacturer
- Wealphar Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01E58
|
893100031524 |
1g
Oral
|
Tablet |
33,500
|
987
|
33,064,500
|
N5 |
Wealphar Pharmaceutical JSC
Vietnam
|
Hanoi
01E58
|
2026-03-27 |
|
Suprane
Desfluran
- Strength / route
- 100% (v/v) · Inhalation
- Qty
- 150 Chai
- Total
- 405,000,000
- Group
- N1
- Manufacturer
- Baxter Healthcare Corporation (United States)
- Province / Facility
- Ho Chi Minh City · 79431
|
VN-17261-13 |
100% (v/v)
Inhalation
|
Chai |
150
|
2,700,000
|
405,000,000
|
N1 |
Baxter Healthcare Corporation
United States
|
Ho Chi Minh City
79431
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 300 Canister
- Total
- 130,200,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hai Duong · 30013
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
300
|
434,000
|
130,200,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hai Duong
30013
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 50 Canister
- Total
- 21,700,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hanoi · 01107
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
50
|
434,000
|
21,700,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hanoi
01107
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonid + formoterol
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 100 Canister
- Total
- 43,400,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hanoi · 01055
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
100
|
434,000
|
43,400,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hanoi
01055
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 50 Canister
- Total
- 21,700,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hanoi · 01OR2
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
50
|
434,000
|
21,700,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hanoi
01OR2
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 50 Canister
- Total
- 21,700,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hanoi · 01E53
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
50
|
434,000
|
21,700,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hanoi
01E53
|
2026-03-27 |
|
Symbicort Rapihaler
Budesonide; Formoterol fumarate dihydrate
- Strength / route
- each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose · Inhalation
- Qty
- 50 Canister
- Total
- 21,700,000
- Group
- N1
- Manufacturer
- AstraZeneca Dunkerque Production (France)
- Province / Facility
- Hanoi · 01E64
|
300110006424 |
each dose xit contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 120 dose
Inhalation
|
Canister |
50
|
434,000
|
21,700,000
|
N1 |
AstraZeneca Dunkerque Production
France
|
Hanoi
01E64
|
2026-03-27 |
